Fractyl Health, Inc. Common Stock (GUTS)

Fractyl Health, Inc. Common Stock (GUTS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $20.6M; returns 1 day -4.4%, 1 week -30.3%, 1 year -93.5%.

Fractyl Health Inc. (GUTS) is a clinical-stage metabolic therapeutics company dedicated to pioneering novel treatments for the root causes of type 2 diabetes (T2D) and obesity.

Groups GUTS belongs to

• Recent Reverse Splits
• Clinical Stage Biotech
• Metabolic Disorders
• Biotechnology
• Healthcare
• Weight Management
• Type 1 Diabetes
• Gene Therapy
• Medical Devices
• GLP-1 Agonists
• Minimally Invasive Surgery

GUTS financial model: income statement, cash flow and balance sheet